Can a single gene therapy injection ease diabetic macular edema?
Disease control
Completed
This phase 1 trial tests an experimental gene therapy called SKG0106, given as an injection into the eye, for people with diabetic macular edema, a complication of diabetes that causes blurred vision. The study enrolls a small group of adults with type 1 or type 2 diabetes whose …
Phase 1 • Sponsor: Wang Min • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC